Laboratory Corporation of America Holdings at Morgan Stanley Healthcare Conference Transcript
So good morning, everybody. I'm Ricky Goldwasser. I'm Morgan Stanley's healthcare services analyst. Before we start, just a reminder that for any personal and Morgan Stanley disclosure, please go to the Morgan Stanley website or to our desk.
So I have the very great pleasure of having the entire LabCorp executive team here. So to my left, David King, President and CEO. To Dave's left, Adam Schechter, who's the incoming CEO; and Glenn Eisenberg, LabCorp's CFO.
So Dave, Adam and Glenn, thank you for coming in kind of like for the full team.
Thanks for having us.
Questions & Answers
So 2019, it's certainly had to be a transformative year for LabCorp and for the industry. We have kind of like new payer agreements. You guys are doing -- did another acquisition on the CRO side.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |